That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address.

Eric Benjamin Biography and Net Worth

SVP of Insulet

Mr. Benjamin has served as our Executive Vice President, Innovation and Strategy since March 2022. Prior, he served as our Senior Vice President, Innovation and Strategy since February 2020. From February 2018 to January 2020, he served as Senior Vice President, R&D, New Product Development and Commercialization, from February 2016 to January 2018 he served as Vice President, Procurement and Supplier Development, and from June 2015 to January 2016 he served as Director, Business Development. Prior to joining Insulet, Mr. Benjamin held roles of increasing responsibility spanning R&D, Manufacturing, and Quality with Abbott Laboratories. Mr. Benjamin earned a Bachelor of Science in Industrial Engineering and Operations Research from the University of California at Berkeley, a Master of Engineering in Bioengineering from the University of California at San Diego, and a Master of Business Administration from Harvard Business School.

How old is Eric Benjamin?: Mr. Benjamin is currently 41 years old. There are 9 older executives and no younger executives at Insulet. The oldest executive at Insulet is Mr. John Wodick Kapples, Senior VP & General Counsel, who is 64 years old. Learn More on Eric Benjamin's age.
How do I contact Eric Benjamin?: The corporate mailing address for Mr. Benjamin and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at [email protected]. Learn More on Eric Benjamin's contact information.
Has Eric Benjamin been buying or selling shares of Insulet?: Eric Benjamin has not been actively trading shares of Insulet within the last three months. Most recently, Eric Benjamin sold 14,912 shares of the business's stock in a transaction on Thursday, July 23rd. The shares were sold at an average price of $210.00, for a transaction totalling $3,131,520.00. Learn More on Eric Benjamin's trading history.
Who are Insulet's active insiders?: Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Bret Christensen (EVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), James Hollingshead (CEO), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.
Are insiders buying or selling shares of Insulet?: In the last twelve months, insiders at the medical instruments supplier sold shares 5 times. They sold a total of 25,540 shares worth more than $4,527,624.61. The most recent insider tranaction occured on June, 14th when SVP Mark N Field sold 1,500 shares worth more than $299,940.00. Insiders at Insulet own 0.5% of the company. Learn More about insider trades at Insulet.
Information on this page was last updated on 6/14/2024.

Eric Benjamin Insider Trading History at Insulet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/23/2020	Sell	14,912	$210.00	$3,131,520.00

Eric Benjamin Buying and Selling Activity at Insulet

Insulet Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Today's Range

Now: $267.66

$267.66

50 Day Range

MA: $240.09

$227.79

$275.70

2 Week Range

Now: $267.66

$160.19

$279.40

Volume

231 shs

Average Volume

773,938 shs

Market Capitalization

$18.77 billion

P/E Ratio

45.83

Dividend Yield

N/A

Beta

1.22

This Bull Market Indicator called NVDA at $116

From WealthPress | Ad

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here